| <img alt="" height="1" width="1" />Salix Pharmaceuticals Reports 4Q2009 and FY2009 ResultsMarketWatch (press release)During 2010 we intend to continue our research and development efforts, specifically the submission of NDAs for XIFAXAN 550 mg for irritable bowel syndrome ...Salix anticipates robust growth<nobr>News & Observer</nobr><nobr>all 28 news articles »</nobr> |
Google- Salix Pharmaceuticals Reports 4Q2009 and FY2009 Results - MarketWatch (press release)
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Join the discussion
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Recommended Communities
Join now to ask and comment!